We see research as being at the heart of improving services for our service users and developing new treatments for use not just locally but nationally and internationally.

CNWL is one of the leading trusts in the country in mental health research. We work closely with Universities both locally and nationally, in particular with Imperial College London.

You may want to find out what research we have under way. You may want to find out whether you could carry out a particular study in the Trust and how to get approval. Or you may want to know whether there is any research under way that you could take part in as a participant.

We've developed a research website which introduces you to our programme, tells you about some of our leading researchers and their work and explains how to get in touch with our research office:

Read our Performance in Initiation and Delivery Report for Quarter 2, 2019-2020

Read our Performance in Initiation and Delivery Report for Quarter 1, 2019-2020

Read our Performance in Initiation and Delivery Report for Quarter 4, 2018-2019

Read our Performance in Initiation and Delivery Report for Quarter 3, 2018-2019

Read our Performance in Initiation and Delivery Report for Quarter 2, 2018-2019

Read our Performance in Initiation and Delivery Report for Quarter 1, 2018-2019

Read our Performance in Initiation and Delivery Report for Quarter 4, 2017-2018

Read our Performance in Initiation and Delivery Report for Quarter 3, 2017-2018

Read our Performance in Initiation and Delivery Report for Quarter 2, 2017-2018

Read our Performance in Initiation and Delivery Report for Quarter 1, 2017-2018

Read our Performance in Initiation and Delivery Report for Quarter 4, 2016-2017

Read our Performance in Initiation and Delivery Report for Quarter 3, 2016-2017

Read our Performance in Initiation and Delivery Report for Quarter 2, 2016-2017

Read our Performance in Initiation and Delivery Report for Quarter 4, 2015-2016

Read our Performance in Initiation and Delivery Report for Quarter 3, 2015-2016

Read our Performance in Initiation and Delivery Report for Quarter 2, 2015-2016

Read our Performance in Initiation and Delivery Report for Quarter 1,  2015-2016

Read our Performance in Initiation and Delivery Report for Quarter 4, 2014-2015

Read our Performance in Initiation and Delivery Report for Quarter 3, 2013-2014

Academic profiles

Richard Watt.jpg


Richard Watt is Director of Research, Development and Innovation at Central North West London NHS Foundation Trust and Professor and Honorary Consultant in Dental Public Health at UCL. In 2019 he was appointed as Director of the World Health Organisation Collaborating Centre for Oral Health Inequalities and Public Health at UCL.

After qualifying as a dentist from the University of Edinburgh he worked in the NHS community dental service and then studied for a MSc and PhD in Dental Public Health at UCL. For the past 28 years he has been an academic in the UCL Department of Epidemiology and Public Health. He is currently leading a NIHR funded trial evaluating a community based parenting intervention.

Research interests include:

  • Understanding the underlying causes of (oral) health inequalities
  • Development and evaluation of community-based health improvement interventions
  • Association between oral and general health through common risk factor approach
  • Evidence base for legislative and regulatory policies to promote health

Selectied publications:

  • Batty GD, Zaninotto P, Watt RG, Bell S. (2017). Associations of pet ownership with biomarkers of ageing: population based cohort study. British Medical Journal 13;359:j5558.
  • Watt RG, Mathur M, Aida J, Bonecker M, Venturelli R, Gansky, S. (2018). Oral health disparities in children – a canary in the coalmine? Pediatric Clinics of North America. 65:965-979
  • Peres M, Macpherson LM, Weyant RJ, Daly B, Venturelli R, Mathur MR, Listl S, Celeste RK, Guarnizo-Herreño CC, Kearns C, Benzian H, Allison P, Watt RG. (2019). Oral diseases: a global public health challenge. The Lancet 394:249-259
  • Watt RG, Daly B, Allison P, Macpherson LM, Venturelli R, Listl S, Weyant RJ, Mathur MR, Guarnizo-Herreño CC, Kearns C, Celeste RK, Peres M, Benzian H. (2019). Ending the neglect of global oral health - time for radical action The Lancet 394:261-272.
  • Watt RG, Venturelli R, Daly B (2019). Understanding and tackling oral health inequalities in vulnerable adult populations: from the margins to the mainstream. British Dental Journal 227(1):49-54.

Further details of his academic work can be found online.



Mike Crawford.jpg

Mike Crawford is Professor of Mental Health Research at Imperial College London and an honorary consultant psychiatrist at Central and North West London NHS Foundation Trust. He is also Director of the Centre for Quality Improvement at the Royal College of Psychiatrists where he oversees the national mental health audit programme.

After completing his medical training at King’s College London he trained in psychiatry at the Royal Free and the Maudsley Hospitals. He completed an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine and an MD on the management of suicidal behaviour at the University of London. In 2004 he worked with colleagues to set up the Waterview Centre, the first specialist service for people with a diagnosis of personality disorder at the Trust. Mike was appointed as an NIHR Senior Investigator in 2019. He is currently working on trials of psychological and pharmacological interventions for people with personality disorder.

Research interest include:

  • The evaluation of complex psychosocial interventions for people with severe mental health conditions
  • The relationship between the process and outcomes of care delivered to people who have poor mental health
  • The development and evaluation of methods for assessing and improving the quality of mental health services
  • The role of adjuvant pharmacotherapy for people with severe personality disorder

Selected publications:

Crawford M, Huddart D, Craig E et al. (2019) Impact of secondary care financial incentives on the quality of physical health care for people with psychosis. British Journal of Psychiatry doi: 10.1192/bjp.2019.162

Lei H, Barnicot K, Maynard E, Etherington A, Zalewska K, Quirk A, Sanatinia R, Cooper SJ, Crawford MJ. (2019)  Factors influencing use of Community Treatment Orders and quality of care that people receive. BJPsych Bulletin 43: 227–235. doi:10.1192/bjb.2019.23

Shastri A, Aimola L, Took B, Quirk A, Corrado O, Crawford MJ (2019) Recognition and treatment of depression in older adults admitted to acute hospitals in England. Clinical Medicine 19: 114–118. doi: 10.7861/clinmedicine.19-2-114

Barnicot K, Crawford MJ (2018) Dialectical behaviour therapy versus mentalization-based therapy for borderline personality disorder. Psychological Medicine 49: 2060-2068. doi.org/10.1017/ S0033291718002878

Crawford MJ, Sanatinia R, Barrett B, et al. (2018) The clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder: A randomized placebo-controlled trial. American Journal of Psychiatry 175:756–764. doi.org/10.1176/appi.ajp.2018.17091006

Further details of his academic work can be found online.


Judith Stephenson.jpg

Judith Stephenson is the Margaret Pyke Professor of Sexual & Reproductive Health at UCL, and Honorary Consultant in Sexual & Reproductive Health at CNWL and Honorary Consultant in Women’s Health at UCLH.

After training in clinical medicine at the University of Oxford and UCL Medical School and junior hospital doctor posts in London, she studied epidemiology at the London School of Hygiene & Tropical Medicine.  For the past 30 years she has held academic posts at UCL, first in HIV and Sexually Transmitted Disease Epidemiology, and currently in Women’s Reproductive Health.

Judith’s research has changed policy and practice nationally and internationally, e.g. in relation to chlamydia screening and preconception health.  Her current research spans prevention of pregnancy https://www.contraceptionchoices.org, planning and preparation for pregnancy and how the preconception period influences mother and child health across the life course.

She received the UCL prize for Leadership in Public Engagement in 2012, an NIHR Senior Investigator Awards in 2014, renewed in 2019 and the Women of Achievement in Healthcare Award from Women in the City, 2015.

Selected publications:

  • Stephenson J, Vogel C, Hall J, Hutchinson J, Mann S, Duncan H, Woods-Townsend K, de Lusignan S, Poston L, Cade J,  Godfrey K, Hanson M, Barrett G, Barker M, Conti G, Shannon F, Colbourn T, for the Preconception Partnership (2019). Preconception health in England: a proposal for annual reporting with core metrics. The Lancet doi: 10.1016/S0140-6736(18)30311-8
  • Stephenson J, Heslehurst N, Hall J, Schoenaker D, Hutchinson J, Cade J, Poston L, Barrett G, Crozier S, Kumaran K,  Yanjik C, Barker M, Baird J & Mishra G (2018). Lancet series on preconception health Paper 1 - Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health. The Lancet doi: 10.1016/S0140-6736(18)30311-8
  • Fleming T, Watkins A, Velazquez MA, Mathers JC, Prentice AM, Stephenson J, Barker ME, Saffery R, Yajnik CS, Eckert JJ, Hanson MA, Forrester T, Gluckman PD & Godfrey KM (2018). Lancet series on preconception health Paper 2 - Origins of lifetime health around the time of conception: causes and consequences. The Lancet doi:10.1016/S0140-6736(18)30312-X
  • Barker M, Dombrowski SU, Colbourn T, Fall CHD, Kriznik NM, Lawrence W, Norris SA, Ngaiza G, Patel D, Skordis-Worrall J, Sniehotta FF, Steegers-Theunissen R, Vogel C, Woods-Townsend K & Stephenson J (2018). Lancet series on preconception health Paper 3 - Intervention strategies to improve nutrition and health behaviours before conception. The Lancet doi: 10.1016/S0140-6736(18)30313-1
  • Stephenson, JM., Shawe, J., Panicker, S., Brima, N., Copas, A., Sauer, U, O’Brien, P. (2013). Randomised trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at one year. Contraception, 88 (4), 523-531

Further details of her academic work can be found online.


Claudia Estcourt.JPG

Claudia Estcourt is an Honorary Consultant at Central North West London NHS Foundation Trust and Honorary Professor in Sexual Health & HIV at UCL, Professor of Sexual Health & HIV at Glasgow Caledonian University and Honorary Consultant in NHS Greater Glasgow & Clyde.

After qualifying from the University of Newcastle upon Tyne, her clinical and research roles have taken her to Manchester, Paris, Sydney, and latterly splitting her time between Glasgow and CNWL where she leads an NIHR Programme for Applied Research which focusses on improving sexual health through prevention of transmission of STIs and HIV.  She leads evaluation of Scotland’s HIV PrEP programme.

Research interests include:

  • Partner notification to prevent STI & HIV transmission
  • eSexual Health in UK and LMICs
  • Public health and health service interventions for HIV PrEP

Selected publications:

  • Estcourt CS, Gibbs J, Sutcliffe LJ, Gkatzidou V, Tickle L, Hone K, Aicken C, Lowndes CM, Harding-Esch EM, Eaton S, Oakeshott P, Szczepura A, Ashcroft RE, Copas A, Nettleship A, Sadiq ST, Sonnenberg P. The eSexual Health Clinic System management, prevention and control of sexually transmitted infections: exploratory studies in people testing for Chlamydia
  • Estcourt CS, Sutcliffe L, Mercer C, et al The Ballseye Programme: targeting men for better sexual health. NIHR Journals Libr Health Technol Assess, 2017. https://www.journalslibrary.nihr.ac.uk/pgfar/pgfar04200/#/abstract . Also highlighted in an NIHR Signal 29.3.17:  https://discover.dc.nihr.ac.uk/portal/article/4000621/men-find-self-testing-acceptable-to-test-for-sexually-transmitted-infections 
  • Flowers P, Estcourt C, Sonnenberg P, Burns F. HIV testing intervention development among men who have sex with men in the developed world. Sexual Health 2017, UI28080947, http://dx.doi.org/10.1071/SH16081
  • Birger R; Saunders J; Estcourt C; Sutton AJ; Mercer CH; Roberts T; White PJ. Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model. Scientific Reports. 7(1):16162, 2017 Nov 23.www.nature.com/articles/s41598-017-16302-8
  • Mercer CH, Jones KG, Johnson AM, Lewis R, Mitchell KR, Gravningen K, Clifton S, Tanton C, Sonnenberg P, Wellings K, Cassell JA, Estcourt CS. How can we objectively categorise partnership type? A novel classification of population survey data to inform epidemiological research and clinical practice. Sex Transm Infect 2017;93:129-136. UI 27535765

Further details of her academic work can be found online.



Alejandro Arenas-Pinto.jpg

Alejandro is a Principal Clinical Research Fellow at the UCL Centre for Clinical Research in Infection and Sexual Health, which is part of the Institute for Global Health, and the MRC Clinical Trials Unit within the UCL Institute of Clinical Trials and Methodology. He is also an honorary HIV Specialist Doctor with the Central North West London NHS Foundation Trust.

He is a Venezuelan physician with training in infectious diseases. In the UK he completed his MSc in Infectious and Health in the Tropics at the London School of Hygiene and Tropical Medicine (Distinction) and obtained the Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians. He gained his PhD on HIV disease from University College London in 2006.

Research interests include:

  • Randomised Clinical Trials on HIV treatment strategies.
  • Diagnosis and management of adverse drug reactions induced by anti-retrovirals.
  • Management of comorbidities in people living with HIV, with particular focus on neuropsychiatric and metabolic complications.
  • Safety and clinical events reporting processes in randomised clinical trials.

Selected publications:

  • Arenas-Pinto, A., Grund, B., Sharma, S., Martinez, E., Cummins, N., Fox, J., Klingman KL, Sedlacek D, Collins S, Flynn PM, Chasanov WM, Kedem E, Katlama C, Sierra-Madero J, Afonso C, Brouwers P, Cooper DA; INSIGHT START study group. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. Clin Infect Dis 2018; 67(3):420-429.
  • Milinkovic A, Berger F, Arenas-Pinto A, Mauss S. Lipid changes due to tenofovir alafenamide are reversible by switching back to tenofovir disoproxil fumarate. AIDS 2019 [Epub ahead of print]
  • Dharan, N. J., Neuhaus, J., Rockstroh, J. K., Peters, L., Gordin, F., Arenas-Pinto, A., Emerson C, Marks K, Hidalgo J, Sarmento-Castro R, Stephan C, Kumarasamy N, Emery S, Matthews GV;INSIGHT START Study Group. Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial. Hepatology 2019 Mar; 69(3):1135-1150.
  • Haddow, L. J., Godi, C., Sokolska, M., Cardoso, M. J., Oliver, R., Winston, A., Stöhr W, Clarke A, Chen F, Williams IG, Johnson M, Paton N, Arenas-Pinto A, Golay X,Jäger, H. R. Brain perfusion, regional volumes and cognitive function in HIV positive patients treated with protease inhibitor monotherapy. Clin Infect Dis 2019; 68(6):1031-40.
  • Wright, E. J., Grund, B., Robertson, K. R., Cysique, L., Brew, B. J., Collins, G. L., Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, Mueller NJ, Winston A, Nsubuga MS, Lal L, Price RW; INSIGHT START Neurology Substudy Group. No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts. AIDS 2018; 32(8):985-97

Further details of his academic work can be found online.


Chantal Edge.jpg


Chantal Edge is a Specialty Registrar in Public Health and an NIHR Clinical Doctoral Research Fellow based at UCL. She leads on prison health research within the UCL Collaborative Centre for Inclusion Health and holds an honorary research position within the Offender Care team at Central North West London NHS Foundation Trust.

Chantal’s research focusses on the use of video consultations (telemedicine) within CNWL prisons to improve the access and quality of secondary care for patients.

Research interests include: 

  • Improving health services and patient outcomes in prisons, in line with the principle of equivalence
  • Improving the interface between prison health and community health services
  • Development and evaluation of interventions for inclusion health groups

Selected publications:

  • Edge CL, Black G, King EJ, George J, Patel S, Hayward A (2019). Improving care quality with prison telemedicine: the effects of context and multiplicity on successful implementation and use. In press Journal of Telemedicine and Telecare
  • Edge CL, King EJ, Dolan K, McKee, M. (2016) Prisoners co-infected with TB and HIV: a systematic review. J Int AIDS Soc. 2016 Nov 15; 19(1):20960.
  • Edge CL, Waight P, Ribiero S, Borrow R, Ramsay M, Ladhani S (2016) Clinical characteristics and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: linkage analysis of multiple national databases Journal of Infection 2016 July 73; 5:427-436

Further details of her academic work can be found online.

Dasha Nicholls is Clinical Reader in Child Psychiatry at Imperial College London and Honorary Consultant in Child and Adolescent Psychiatry at CNWL. Dasha moved to Imperial College in 2018 after more than 20 years at Great Ormond Street Hospital where she co-led the National Feeding and Eating Disorders Service. She leads the Child and Adolescent Mental Health research team in the Division of Psychiatry, and is Deputy Lead of the Division. Dasha is the lead for Multimorbidity within the North West London Applied Research Collaboration (ARC), and lead for Mental Health. She oversees the CNWL training academy for CAMHS and Eating Disorders.

After qualifying in Medicine in 1988 she started training in Psychiatry in Eastbourne, before moving to UCL and then onto Great Ormond Street for higher training in Child Psychiatry. She is past chair of the Eating Disorders Faculty of the Royal College of Psychiatrists and Past President of the Academy of Eating Disorders. She led development of national guidelines for the management of seriously ill young people with anorexia nervosa, and has served on the NICE guideline committee for eating disorders and other national bodies to improve care and services for people with eating disorders. Dasha also co-founded the Child and Adolescent Psychiatric Surveillance System (CAPSS) for research into rare disorders and events in child mental health.

Research interests include:

  • Social, psychological and biological risk factors for eating disorders
  • Prevention and early intervention for disordered eating behaviour in young people
  • The impact of social media on mental health
  • The relationship between physical and mental health in young people

Recent publications (5 max):


  1. Byford SPetkova HStuart RNicholls DSimic MFord TMacdonald GGowers SRoberts SBarrett BKelly JKelly GLivingstone NJoshi KSmith HEisler I. Alternative community-based models of care for young people with anorexia nervosa: the CostED national surveillance study. Southampton (UK): NIHR Journals Library; 2019.
  2. Neale J, Pais SMA, Nicholls D, Chapman S, Hudson LD. What Are the Effects of Restrictive Eating Disorders on Growth and Puberty and Are Effects Permanent? A Systematic Review and Meta-Analysis. J Adolesc Health. 2019 Nov 23. doi: 10.1016/j.jadohealth.2019.08.032.
  3. Petkova H, Ford T, Nicholls D, Stuart R, Livingstone N, Kelly G, Simic M, Eisler I, Gowers S, Macdonald G, Barrett B, Byford S. Incidence of anorexia nervosa in young people in the British Isles. BMJ Open 2019 Oct 22;9(10)
  4. Viner RM, Aswathikutty-Gireesh A, Stiglic N, Hudson LD, Goddings AL, Ward JL, Nicholls DE. Roles of cyberbullying, sleep, and physical activity in mediating the effects of social media use on mental health and wellbeing among young people in England: a secondary analysis of longitudinal data. Lancet Child Adolesc Health. 2019 Oct;3(10):685-696.
  5. Nicholls D, Becker A. Food for Thought: Bringing Eating Disorders out of the shadows. BJPsych 2019 Jul 26:1-2.

For more information visit this page

Shema Tariq.jpg


Dr Shema Tariq is a Clinical Research Fellow at UCL’s Institute for Global Health, and Honorary Consultant HIV Physician at Mortimer Market Centre.  She has a number of national roles including Chair of the British Association of Sexual Health and HIV’s Lay Public Research Panel, and Trustee of Positively UK.  She is also immediate past Vice-Chair of the British HIV Association’s Pregnancy and HIV Guidelines Committee.

Shema qualified in Medicine from Newcastle University in 1999.  She has Masters in both Medical Anthropology and Epidemiology, and a PhD in Public Health from City University London (2013).  She has held a Fulbright Scholarship at Columbia University, New York and an NIHR postdoctoral research fellowship at UCL.

Research interests

  • HIV and women including pregnancy, menopause and research participation
  • The use of digital technology to support long term HIV care
  • Patient and public involvement in research

Recent publications:

  • Hay K, Kwardem L, Tariq S, Coventry L, Namiba A, Dhairyawan R, Durrant A. Support for the Supporters”: A Qualitative Study of the use of WhatsApp by and for Mentor Mothers with HIV in the UK. AIDS Care In Press.
  • Namiba A, Kwardem L, Mbewe R, Murau F, Bewley S, Tariq S, Welbourn A.  Perinatal peer mentoring, sexual and reproductive health and rights, and HIV. In “Complex Social Issues and the Perinatal Woman”: to be published by Springer in 2020.
  • Toorabally N, Mercer C H, Mitchell K R, Blell M, Burns F, Gilson R, . . . Tariq S. (2019). Association of HIV status with sexual function in women aged 45-60 in England: results from two national surveys. AIDS Care. 2019:  1-10.
  • Tariq S & BMS Medical Advisory Council. (2019). British Menopause Society Tools for Clinicians: HIV and the menopause. Post Reprod Health.  2019: 25 (1), 38-39.
  • Tariq S, Burns F M, Gilson R, Sabin C.  PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England. BMJ Open. 2019: 9 (6), e025497.

Further details are on this website




Professor Anne Lingford-Hughes is Professor of Addiction Biology at Imperial College and Head, Centre for Psychiatry. She is also a Consultant Psychiatrist in addictions at Central North West London NHS Foundation Trust. She graduated in medicine from Oxford University, completed her PhD at Cambridge University, and trained in psychiatry at The Bethlem and Maudsley Hospitals and Institute of Psychiatry. She is currently Chair of the Academic Faculty of Royal College of Psychiatrists and Professional Liaison Officer, British Neuroscience Association. She also leads an MRC funded PhD programme to produce future clinical addiction academic leaders – MARC.

Research interests :

  • Using neuroimaging, pharmacological and behavioural challenges to characterize the neurobiology of addiction to alcohol, opiate, cocaine, gambling and nicotine

Current projects

  • Assessing brain responses during methadone detoxification and early abstinence and their modulation by NK1 antagonism
  • Assessing brain responses to baclofen in alcoholism.

See more on this website


1.  Limbrick-Oldfield EH, Mick I, Cocks RE, Flechais RSA, Turton S, Lingford-Hughes A, Bowden-Jones H, Clark L. Neural and neurocognitive markers of vulnerability to gambling disorder: a study of unaffected siblings. Neuropsychopharmacology. 2019 Oct Epub

2. Durant CF, Paterson LM, Turton S, Wilson SJ, Myers JFM, Muthukumaraswamy S, Venkataraman A, Mick I, Paterson S, Jones T, Nahar LK, Cordero RE, Nutt DJ, Lingford-Hughes A. Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures. Front Psychiatry. 2018 Dec 14;9:664.

3. Turton S, Myers JF, Mick I, Colasanti A, Venkataraman A, Durant C, Waldman A, Brailsford A, Parkin MC, Dawe G, Rabiner EA, Gunn RN, Lightman SL, Nutt DJ, Lingford-Hughes A. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals. Mol Psychiatry. 2018 Jun 25.

4.  Quelch DR, Mick I, McGonigle J, Ramos AC, Flechais RS, Bolstridge M, Rabiner E, Wall MB, Newbould RD, Steiniger-Brach B, van den Berg F, Boyce M, Østergaard Nilausen D, Breuning Sluth L, Meulien D, von der Goltz C, Nutt D, Lingford-Hughes A. (2017) Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study. Biol Psychiatry. 81(11):941-948

5.  Paterson LM, Flechais RS, Murphy A, Reed LJ, Abbott S, Boyapati V, Elliott R, Erritzoe D, Ersche KD, Faluyi Y, Faravelli L, Fernandez-Egea E, Kalk NJ, Kuchibatla SS, McGonigle J, Metastasio A, Mick I, Nestor L, Orban C, Passetti F, Rabiner EA, Smith DG, Suckling J, Tait R, Taylor EM, Waldman AD, Robbins TW, Deakin JW, Nutt DJ, Lingford-Hughes AR; ICCAM Platform. (2015) The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description. J Psychopharmacol. 29(9):943-60.


Fi Burns.jpg


Dr Fiona Burns PhD, FRCP, is HIV Clinical Lead at the Royal Free Hospital, London and an Associate Professor in Sexual Health and HIV at University College London. Her research interests are in the social and behavioural dimensions of HIV/STI epidemiology, with a particular interest in health care access, engagement and social inequalities, as well as migrant health. She co-led on the BHIVA Standards of Care for people living with HIV 2018. She undertook her medical training at Otago University in New Zealand before moving to the UK in 1995.

Recent publications:

Witzel TC, Weatherburn P, Bourne A, Rodger AJ, Bonell C, Gafos M, Trevelion R, Speakman A, Lampe F, Ward D, Dunn DT, Gabriel MM, McCabe L, Harbottle J, Collaco Maraes Y, Michie S, Phillips A, McCormack S, Burns FM (2020) Exploring Mechanisms of Action: Using a Testing Typology to Understand Intervention Performance in an HIV Self-Testing RCT in England and Wales. Int. J. Environ. Res. Health 17, 466; doi:10.3390/ijerph17020466

Fakoya I, Logan L, Ssanyu-Sseruma W, Howarth A, Murphy G,  Johnson AM, Nardone A, Rodger AJ, Burns F (2019) HIV testing and sexual health among black African men and women in London. JAMA Open 2(3):e190864. doi:10.1001/jamanetworkopen.2019.0864)

Fakoya I, Álvarez-Del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, Wendenroth C,  Touloumi G, Prins M, Barros H, Darling KEA, Prestileo T, del Amo J*, Burns F*   on behalf of the aMASE Study Team (2018) HIV testing history and access to treatment among migrants living with HIV in Europe. Journal of the International AIDS Society v.21 (S4):e25123

Alvarez-del Arco D, Fakoya I, Thomadakis C, Pantazis N, Touloumi G, Gennotte A, Zuure F, Barros H, Staehelin C, Göpel S, Boesecke C, Prestileo T, Volny-Anne A, Burns F*, del Amo J* on behalf of the aMASE (Advancing Migrant Access to Health Services in Europe) study team (2017) High levels of post-migration HIV acquisition within nine European countries. AIDS Sep 10;31(14):1979-1988

Sabin C A, Howarth A, Jose S, Hill T, Apea V,  Morris S, Burns F on behalf of the UK CHIC Study Group and the REACH Study Group (2017) Association between engagement in-care and mortality in HIV-positive persons. AIDS 31 (5): 653–660 doi: 10.1097/QAD.0000000000001373

Further details of his academic work can be found on this website

*joint final author.



Shoumi Deb.jpg

Shoumi is a Visiting Professor of Neuropsychiatry at the Imperial College London, and an honorary consultant in CNWL NHS Trust. Previously he was a full time Clinical Professor at the University of Birmingham. His seminal works include the first ever comprehensive neuropsychiatric outcome study in adults with traumatic brain injury, development of patient and carer determined outcome measures for these patients and their carers, and the first ever comprehensive assessment of psychopathology in adults with intellectual disabilities (ID) and epilepsy. He has over 220 publications and made over 220 presentations at National and International conferences (including many Keynote speeches).

He was a member of several UK NICE GDG and a Fellow of the NIHR. He was a member of the WHO Working Group on ICD-11 and led the development of the first ever European Guide on psychiatric diagnosis in adults with ID and the International Guide on the use of psychotropic medication in this population. He developed a screening instrument for dementia in people with ID which has been translated into more than 20 languages for worldwide use. His citation index is 5749, H-Index is 40 and i10 is 80 (24.02.20). He has received over £3 million research grants and led a team of 21 research and teaching staff. He led several MSc courses at the University of Birmingham and Cardiff (Psychological Medicine, Epilepsy, Neuropsychiatry and International ID).

Research interests include:

  • Neuropsychiatry of traumatic brain injury
  • Psychopharmacology of neuropsychiatry of traumatic brain injury
  • Psychopathology in adult neurodevelopmental disorders (Intellectual Disabilities, ASD, ADHD)
  • Psychopharmacology of Intellectual Disabilities.

Recent publications:

  1. Bertelli M. O., Deb S., Munir K., Hassiotis A. & Salvador-Carulla L. (Eds.) (2020). 'Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder' Springer International Publishing, Cham, Switzerland & World Psychiatric Association, Geneva, Switzerland (book) (in press).
  2. Deb S. & Deb T. (2020) Neuropsychiatry of aggression. In 'Oxford Textbook of Neuropsychiatry' (Eds. R. Faruqui, M Bodani and N. Agrawal). Oxford University Press (book chapter) (in press).
  3. Shankar R., Wilcock M., Deb S. et al. (2019) A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience. Journal of Applied Research in Intellectual Disability, 32, 1389-1400.
  4. Deb S., Leeson V., Aimola L., Bodani M., Lucia L., Weaver, T., Sharp D. & Crawford M. (2018) Aggression Following Traumatic brain injury: Effectiveness of Risperidone (AFTER)-a feasibility RCT: study protocol for a randomised controlled trial. Trials. 19:325, P. 1-10.
  5. Tarrant N., Roy M., Deb S. et al. (2018) The effectiveness of methylphenidate in the management of Attention Deficit Hyperactivity Disorder (ADHD) in people with intellectual disabilities: a systematic review. Research in Developmental Disabilities, 83, 217-232.

Further details of his academic work can be found on this website.